b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30537624</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>29</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>29</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1873-376X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>1104</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jan</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</Title>\n                <ISOAbbreviation>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5\xce\xb1-abiraterone, and their inactive glucuronide derivatives.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>249-255</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1570-0232(18)31388-6</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jchromb.2018.12.003</ELocationID>\n            <Abstract>\n                <AbstractText>Abiraterone acetate (AA) is a prodrug of abiraterone, a selective and potent steroidal cytochrome P450 17alpha- hydroxylase-17,20-lyase (CYP17A1) blocking androgen synthesis in the treatment of advanced prostate cancer. Abiraterone (Abi) is metabolized to D(4)-abiraterone (D4A) directly blocking CYP17A1 and other steroidogenic enzymes and antagonizing the androgen receptor (AR). D4A is converted by 5\xce\xb1-reductase to 3-keto-5\xce\xb1-abiraterone (5\xce\xb1-Abi), an AR agonist. Our recent work suggests phase II biotransformation of Abi, D4A and 5\xce\xb1-Abi conjugated to glucuronic acid in vitro leading to four glucuronides (G). We developed and validated a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method using a 6500 Qtrap mass analyzer coupled with a Shimadzu Nexera system for quantification of Abi, its active metabolites and their G derivatives in human plasma samples with deuterated internal standards. Validation was carried out according to FDA guidelines for bioanalytical method and results were within the acceptance limits. Analytes were extracted from 50\xe2\x80\xaf\xce\xbcL of plasma using a solid phase extraction procedure. Multiple reaction monitoring was used with electrospray ionization in a positive mode. Linearity, precision, and accuracy were validated over a large range of concentrations for each compound (range of 0.5-100\xe2\x80\xafng/mL for Abi and for metabolites and 0.05-10.00\xe2\x80\xafng/mL for glucuronides). The method could measure all seven analytes with sensitivity, accuracy (87-106%), and reproducibility (CV\xe2\x80\xaf&lt;\xe2\x80\xaf10.7%). Its clinical application was further examined with plasma samples obtained from prostate cancer patients under AA treatment. This reliable and validated LC-MS/MS method could be a useful tool for human biomonitoring studies.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Caron</LastName>\n                    <ForeName>Patrick</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacogenomics Laboratory, Centre Hospitalier Universitaire (CHU) de Qu\xc3\xa9bec, - Universit\xc3\xa9 Laval Research Center and Faculty of Pharmacy, Laval University, Qu\xc3\xa9bec city, QC, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Turcotte</LastName>\n                    <ForeName>V\xc3\xa9ronique</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacogenomics Laboratory, Centre Hospitalier Universitaire (CHU) de Qu\xc3\xa9bec, - Universit\xc3\xa9 Laval Research Center and Faculty of Pharmacy, Laval University, Qu\xc3\xa9bec city, QC, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>L\xc3\xa9vesque</LastName>\n                    <ForeName>Eric</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>CHU de Qu\xc3\xa9bec Research Center and Faculty of Medicine, Laval University, Qu\xc3\xa9bec city, QC, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Guillemette</LastName>\n                    <ForeName>Chantal</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacogenomics Laboratory, Centre Hospitalier Universitaire (CHU) de Qu\xc3\xa9bec, - Universit\xc3\xa9 Laval Research Center and Faculty of Pharmacy, Laval University, Qu\xc3\xa9bec city, QC, Canada; Canada Research Chair in Pharmacogenomics, Canada. Electronic address: chantal.guillemette@crchudequebec.ulaval.ca.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>J Chromatogr B Analyt Technol Biomed Life Sci</MedlineTA>\n            <NlmUniqueID>101139554</NlmUniqueID>\n            <ISSNLinking>1570-0232</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000736">Androstenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D020719">Glucuronides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>G819A456D0</RegistryNumber>\n                <NameOfSubstance UI="C089740">abiraterone</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000736" MajorTopicYN="N">Androstenes</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004355" MajorTopicYN="N">Drug Stability</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020719" MajorTopicYN="N">Glucuronides</DescriptorName>\n                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Abiraterone</Keyword>\n            <Keyword MajorTopicYN="N">Drug monitoring</Keyword>\n            <Keyword MajorTopicYN="N">Glucuronide</Keyword>\n            <Keyword MajorTopicYN="N">Mass spectrometry</Keyword>\n            <Keyword MajorTopicYN="N">Prostate cancer</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>07</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30537624</ArticleId>\n            <ArticleId IdType="pii">S1570-0232(18)31388-6</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jchromb.2018.12.003</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'